Drospirenone Ethinyl Estradiol (Zamine, Yasmin) shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 17, 2026
Also sold as: Zamine, Yasmin, Yaz, Mya
Some Drospirenone Ethinyl Estradiol products are in shortage in Canada (2 of 9 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 31, 2026.
A combined birth control pill used to prevent pregnancy.
Products affected
2 / 9
In shortage since
Apr 16, 2026
Est. full return
Jul 31, 2026
Reports on file
30
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28
3MG
0.03MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02421445 · since Apr 16, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
MYA
0.02MG
3.00MG · TABLET · APOTEX INC
DIN 02415380 · since Jul 14, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Resolved
MYA
0.02MG
3.00MG · TABLET · APOTEX INC
DIN 02415380 · ended Mar 5, 2026 · Disruption of the manufacture of the drug.
Resolved
YASMIN 28
3MG
0.03MG · TABLET · BAYER INC
DIN 02261731 · ended Mar 3, 2026 · Supply center delays
Resolved
MYA
0.02MG
3.00MG · TABLET · APOTEX INC
DIN 02415380 · ended Feb 12, 2026 · Disruption of the manufacture of the drug.
Resolved
ZAMINE 28
0.03MG
3MG · TABLET · APOTEX INC
DIN 02410796 · ended Jan 22, 2026 · Disruption of the manufacture of the drug.
Resolved
DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP
3MG
0.02MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02462060 · ended Dec 12, 2025 · Disruption of the manufacture of the drug.
Resolved
ZAMINE 28
0.03MG
3MG · TABLET · APOTEX INC
DIN 02410796 · ended Dec 4, 2025 · Disruption of the manufacture of the drug.
Resolved
MYA
0.02MG
3.00MG · TABLET · APOTEX INC
DIN 02415380 · ended Nov 6, 2025 · Disruption of the manufacture of the drug.
Resolved
ZAMINE 28
0.03MG
3MG · TABLET · APOTEX INC
DIN 02410796 · ended Sep 18, 2025 · Disruption of the manufacture of the drug.
Resolved
DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21
0.03MG
3MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02421437 · ended Aug 12, 2025 · Disruption of the manufacture of the drug.
Resolved
MYA
0.02MG
3.00MG · TABLET · APOTEX INC
DIN 02415380 · ended May 15, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 30 reports. All reports are on file with Health Canada.
What's happening
Drospirenone Ethinyl Estradiol is currently affected by 2 active shortage reports filed with Health Canada by GLENMARK PHARMACEUTICALS CANADA INC., APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Drospirenone Ethinyl Estradiol is classified under “HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE” (ATC G03AA).
Recent changes
Jul 16, 2026
New report filed
Jul 9, 2026
Estimated end date pushed back : Jul 21, 2026 → Aug 10, 2026
Common questions
What is Drospirenone Ethinyl Estradiol used for?
A combined birth control pill used to prevent pregnancy.
When will Drospirenone Ethinyl Estradiol be back in stock in Canada?
The latest manufacturer estimate is Jul 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Drospirenone Ethinyl Estradiol in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.